Structural Moieties Required for Cinnamaldehyde-Related Compounds to Inhibit Canonical IL-1β Secretion

Suppressing canonical NOD-like receptor protein 3 (NLRP3) inflammasome-mediated interleukin (IL)-1β secretion is a reliable strategy for the development of nutraceutical to prevent chronic inflammatory diseases. This study aimed to find out the functional group responsible for the inhibitory effects of cinnamaldehyde-related compounds on the canonical IL-1β secretion. To address this, the suppressing capacities of six cinnamaldehyde-related compounds were evaluated and compared by using the lipopolysaccharide (LPS)-primed and adenosine 5′-triphosphate (ATP)-activated macrophages. At concentrations of 25~100 μM, cinnamaldehyde and 2-methoxy cinnamaldehyde dose-dependently inhibited IL-1β secretion. In contrast, cinnamic acid, cinnamyl acetate, cinnamyl alcohol and α-methyl cinnamaldehyde did not exert any inhibition. Furthermore, cinnamaldehyde and 2-methoxy cinnamaldehyde diminished expressions of NLRP3 and pro-IL-1β. Meanwhile, cinnamaldehyde and 2-methoxy cinnamaldehyde prevented the ATP-induced reduction of cytosolic pro-caspase-1 and increase of secreted caspase-1. In conclusion, for cinnamaldehyde-related compounds to suppress NLRP3 inflammasome-mediated IL-1β secretion, the propenal group of the side chain was essential, while the substituted group of the aromatic ring played a modifying role. Cinnamaldehyde and 2-methoxy cinnamaldehyde exerted dual abilities to inhibit canonical IL-1β secretion at both stages of priming and activation. Therefore, there might be potential to serve as complementary supplements for the prevention of chronic inflammatory diseases.

[1]  Yi-Huang Chang,et al.  Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion , 2018, Molecules.

[2]  N. Zeng,et al.  Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice , 2017, Immunopharmacology and immunotoxicology.

[3]  Shih-Chieh Lee,et al.  Anti-inflammatory effect of cinnamaldehyde and linalool from the leaf essential oil of Cinnamomum osmophloeum Kanehira in endotoxin-induced mice , 2017, Journal of food and drug analysis.

[4]  S. Benkő,et al.  Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production , 2016, Mediators of inflammation.

[5]  Dong-Mei Zhang,et al.  Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation , 2016, Scientific Reports.

[6]  Sally Freeman,et al.  Inhibiting the Inflammasome: A Chemical Perspective. , 2016, Journal of medicinal chemistry.

[7]  Shui-Tein Chen,et al.  A low toxicity synthetic cinnamaldehyde derivative ameliorates renal inflammation in mice by inhibiting NLRP3 inflammasome and its related signaling pathways. , 2016, Free radical biology & medicine.

[8]  C. Sasakawa,et al.  Molecular mechanisms regulating NLRP3 inflammasome activation , 2015, Cellular and Molecular Immunology.

[9]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[10]  S. Cullen,et al.  Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering Necrosis. , 2015, Cell reports.

[11]  Peter A Keyel,et al.  How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. , 2014, Cytokine.

[12]  Vishva M. Dixit,et al.  Mechanisms and Functions of Inflammasomes , 2014, Cell.

[13]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[14]  Ku-Shang Chang,et al.  Inhibition of neuroinflammation by cinnamon and its main components. , 2013, Food chemistry.

[15]  D. Green,et al.  Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner , 2012, The Journal of Immunology.

[16]  Pei-Hsin Shie,et al.  Anti-Inflammatory Activities of Cinnamomum cassia Constituents In Vitro and In Vivo , 2012, Evidence-based complementary and alternative medicine : eCAM.

[17]  Ling Zhao,et al.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. , 2011, Nutrition reviews.

[18]  C. Dinarello,et al.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.

[19]  Byung Hun Kim,et al.  Regulatory Effect of Cinnamaldehyde on Monocyte/Macrophage-Mediated Inflammatory Responses , 2010, Mediators of inflammation.

[20]  K. Miyake,et al.  Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. , 2008, Biochemical pharmacology.

[21]  H. Chung,et al.  Suppression of age-related inflammatory NF-κB activation by cinnamaldehyde , 2007, Biogerontology.

[22]  Peter G. Schultz,et al.  Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines , 2007, Nature.

[23]  Sun Young Lee,et al.  Inhibitory effect of 2'-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-kappa B activation in RAW 264.7 cells. , 2005, Biochemical pharmacology.

[24]  Hoi-Seon Lee,et al.  Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. , 2002, Journal of agricultural and food chemistry.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  H. Pahl,et al.  Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones* , 2001, The Journal of Biological Chemistry.

[27]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[28]  B. Kwon,et al.  Synthesis andin vitro cytotoxicity of cinnamaldehydes to human solid tumor cells , 1998, Archives of pharmacal research.

[29]  B. Kwon,et al.  Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors , 1997 .

[30]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[31]  A. Goldberg,et al.  Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.